Clinical Trial Update: Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

View source ↗

Summary

This clinical trial compares standard chemotherapy with or without nelarabine or rituximab in newly diagnosed acute lymphoblastic leukemia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Nelarabine (Nelarabine)
• Rituximab (rituximab)

Snippet

Sponsor: University College, London | Conditions: Leukemia, Mucositis | Status: COMPLETED